Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells

CD38 is expressed on Waldenström macroglobulinaemia (WM) cells, but its role as a therapeutic target remains undefined. With recent approval of the anti-CD38 monoclonal antibody, daratumumab (Dara), we hypothesized that blocking CD38 would be lethal to WM cells. In vitro Dara treatment of WM cells (...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Br J Haematol
Huvudupphovsmän: Paulus, Aneel, Manna, Alak, Akhtar, Sharoon, Paulus, Shumail M., Sharma, Mayank, Coignet, Marie V., Jiang, Liuyan, Roy, Vivek, Witzig, Thomas E., Ansell, Stephen M., Allan, John, Furman, Richard, Aulakh, Sonikpreet, Manochakian, Rami, Ailawadhi, Sikander, Chanan-Khan, Asher A., Sher, Taimur
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2018
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7294509/
https://ncbi.nlm.nih.gov/pubmed/30080238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15515
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk